Please ensure Javascript is enabled for purposes of website accessibility

Pa. resumes use of Johnson & Johnson’s COVID-19 vaccine

Pennsylvania has resumed use of Johnson & Johnson’s COVID-19 vaccine, following a thorough federal review which reaffirmed the vaccine’s safety and effectiveness against the virus.

Dawn Ouellette Nixon
Dawn Ouellette Nixon is a career journalist who believes that good journalism can change the world. As the health care reporter, she covers everything from small town medicine to big pharma. You can also find her chasing a good business story in Berks County. She can be reached at dnixon@bridgetowermedia.com. or 610-807-9619, extension 4118.

Business Journal Events

Health Care Summit

Thursday, August 18, 2022
Health Care Summit

Forty Under 40 Awards

Wednesday, September 14, 2022
Forty Under 40 Awards

Reader Rankings Awards

Monday, October 10, 2022
Reader Rankings Awards

Real Estate & Development Summit

Wednesday, October 12, 2022
Real Estate & Development Summit